Skip to Content

Fosfomycin use while Breastfeeding

Drugs containing Fosfomycin: Monurol

Medically reviewed by Drugs.com. Last updated on Apr 14, 2020.

Fosfomycin Levels and Effects while Breastfeeding

Summary of Use during Lactation

Limited information indicates that fosfomycin produces low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months.

Drug Levels

Maternal Levels. After 1 to 2 grams of fosfomycin given by injection, colostrum levels in 2 women were 4.8 mg/L and milk levels were 3.6 mg/L.[1][2] Further details of the studies were not given.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Ciprofloxacin, Levofloxacin, Nitrofurantoin, Trimethoprim

References

1.
Gallego A, Rodriguez A, Mata A. Fosfomycin: pharmacological studies. Drugs Today (Barc). 1974;10 (Suppl):161-8.
2.
Kirby WMM. Pharmacokinetics of fosfomycin. Chemotherapy. 1977;23 (Suppl 1):141-51. [PubMed: 832510]

Substance Identification

Substance Name

Fosfomycin

CAS Registry Number

23155-02-4

Drug Class

  • Breast Feeding
  • Lactation
  • Antibacterial Agents
  • Anti-Infective Agents, Urinary

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.